Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StemSation International is a U.S. OTC-listed company that historically focused on natural wellness products marketed around support of the stem cell and endocannabinoid systems, and more recently has emphasized production and distribution of flavored canned oxygen products. In 2024, the company also announced the acquisition of Gorilla Marketing Group, owner of the AlienHouse vape product line, broadening its portfolio into adjacent lifestyle products. The company operates commercially rather than as a clinical-stage biotech developer, and there is no evidence of a conventional therapeutic drug pipeline or active clinical programs. Public materials also indicate that the company filed to change its name to Smart TrendS Network to reflect its newer business strategy. Overall, it is best characterized as a microcap consumer health and lifestyle products company rather than a research-driven biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StemSation International.